Gary G. Lu, M.D., Ph.D.
Medical Oncology, Hematology


About
Gary G. Lu, M.D., Ph.D., is board certified in hematology, internal medicine, and medical oncology. His approach to patient care centers around compassionate and individualized care. He prioritizes clear and honest communication, ensuring people with cancer and their families understand the diagnosis, treatment options, and potential outcomes. He believes in empowering people by involving them actively in decision-making, while respecting their values and preferences.
Clinically, he stays up to date with the evidence-based therapies and clinical trials to offer the latest options. Simultaneously, Dr. Lu recognizes the importance of managing symptoms and side effects proactively to maintain quality of life throughout treatment. Dr. Lu also emphasizes multidisciplinary collaboration, working closely with nurses, social workers, nutritionists, and other specialists. As a group, they can address all aspects of a patient’s well-being – physical, emotional, and psychosocial. His goal is to provide care that supports a person’s fight against cancer and their overall dignity and comfort.
Experience
Education
Fellowship in Hematology and Oncology
Baylor Scott and White Memorial Hospital, Temple, TX
Residency in Internal Medicine
Drexel University at St. Peter’s University Hospital, New Brunswick, NJ
Medical Doctorate
China Medical University, Shenyang, China
Doctor of Philosophy in Pharmacology and Toxicology
Rutgers University/University of Medicine and Dentistry of New Jersey, Piscataway, NJ
Condition
Anemia
Condition
Bladder CancerCondition
Bone CancerCondition
Brain CancerCondition
Breast CancerCondition
Chronic Lymphocytic LeukemiaCondition
Chronic Myeloid LeukemiaCondition
Colon & Rectal CancerCondition
Esophageal CancerCondition
Gastric CancerCondition
Hemophilia
Condition
Hodgkin LymphomaCondition
Kidney CancerCondition
LeukemiaCondition
Liver CancerCondition
Lung CancerCondition
Lymphoma
Condition
MelanomaCondition
Multiple MyelomaCondition
Myeloproliferative Neoplasms (MPN)Condition
Ovarian CancerCondition
Pancreatic CancerCondition
Prostate CancerCondition
Renal CancerCondition
SarcomaCondition
Skin CancerCondition
Urologic CancersService
Precision MedicineService
High Risk Surveillance and Prevention
Diagnosis
Screening
Treatment
ChemotherapyTreatment
ImmunotherapyTreatment
Hormone TherapyTreatment
Infusion TherapyTreatment
Second Opinion Consultation
Locations